- Trials with a EudraCT protocol (4,905)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (10,928)
4,905 result(s) found for: Ct.
Displaying page 1 of 246.
| EudraCT Number: 2019-004045-33 | Sponsor Protocol Number: NL70759.100.19 | Start Date*: 2020-09-07 |
| Sponsor Name:Catharina Hospital Eindhoven | ||
| Full Title: PredicTive value of FluoR-18 PSMA-1007 PET/CT and anti-3-[18F] FACBC PET/CT before PLND for lymph nodE staging in primary pRostate cancer | ||
| Medical condition: Prostate cancer (PCa) is the most common malignancy amongst men in Western countries. In order to select the most suitable treatment for patients diagnosed with PCa, it is important to stage accu... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2021-003460-27 | Sponsor Protocol Number: 2021-12964 | Start Date*: 2022-01-04 | |||||||||||
| Sponsor Name:Radboudumc | |||||||||||||
| Full Title: CXCR4-directed [68Ga]Ga-PentixaFor PET/CT vs AVS performance in a diagnoStic randomized Trial Ultimately comparing hypertenSion outcome in primary aldosteronism | |||||||||||||
| Medical condition: Primary Aldosteronism | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2021-006570-23 | Sponsor Protocol Number: FAPI-POLMONE-2021 | Start Date*: 2022-03-17 | |||||||||||
| Sponsor Name:AOU DI BOLOGNA POLICLINICO S.ORSOLA-MALPIGHI | |||||||||||||
| Full Title: The Role Of The New Promising Oncological Pet/Ct Tracer [68Ga] Ga-Fapi For Staging Lung Cancer: A Preliminary Study | |||||||||||||
| Medical condition: suspected / newly diagnosed lung cancer in staging, patients already on a conventional staging diagnostic path (including FDG-PET / standard CT) | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-024624-20 | Sponsor Protocol Number: OCRD2010/22 | Start Date*: 2011-07-12 |
| Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge | ||
| Full Title: A Pilot Study Investigating the Sensitivity of 18F-labelled Sodium Fluoride PET-CT for Detecting Skeletal Metastases in Renal Cell Carcinoma compared to Planar Bone Scintigraphy and Multidetector CT | ||
| Medical condition: Metastatic renal cell carcinoma. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2019-001843-37 | Sponsor Protocol Number: 52649 | Start Date*: 2019-08-06 | ||||||||||||||||||||||||||
| Sponsor Name:Radboud University Medical Center | ||||||||||||||||||||||||||||
| Full Title: Imaging of tumour microenvironment in patients with oropharyngeal head and neck squamous cell carcinoma using RGD PET/CT imaging. | ||||||||||||||||||||||||||||
| Medical condition: The aim of this study is to assess differences in tumour microenvironment between HPV positive and HPV negative oropharyngeal head and neck squamous cell carcinoma using [68Ga]Ga-RGD2 PET/CT and p... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
| Trial protocol: NL (Ongoing) | ||||||||||||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||||||||||||
| EudraCT Number: 2019-002462-12 | Sponsor Protocol Number: NL70085.058.19 | Start Date*: 2019-10-22 |
| Sponsor Name:Leiden Universitair Medisch Centrum | ||
| Full Title: Imaging tumor angiogenesis using [18F]-PSMA-1007 PET/CT in patients with colon and gastric cancer. | ||
| Medical condition: Colon and gastric cancer patients | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-003788-13 | Sponsor Protocol Number: 1013 | Start Date*: 2023-09-21 |
| Sponsor Name:Heikki Minn | ||
| Full Title: Molecular theranostics for metastatic prostate cancer: PSMA, FAPI, or both? | ||
| Medical condition: Metastatic prostate cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: FI (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-002093-32 | Sponsor Protocol Number: LUM-002 | Start Date*: 2019-10-24 | |||||||||||
| Sponsor Name:Lument AB | |||||||||||||
| Full Title: Randomised, open, non-inferiority within patient-controlled trial evaluating the diagnostic usefulness of Lumentin® 44 when used as contrast agent in CT-enterography as compared to MRI- enterograph... | |||||||||||||
| Medical condition: None. Lumentin 44 is a contrast agent. The diagnostic usefulness of CT with Lumentin 44 as contrast agent as compared to MRE will be investigated in this trial. Patients with confirmed small bowel... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2022-000123-20 | Sponsor Protocol Number: 202200014 | Start Date*: 2022-08-16 |
| Sponsor Name:University Medical Centre Groningen | ||
| Full Title: Prospective, single-centre, feasibility study to evaluate the use of 18F-PSMA PET/CT in patients with biochemically active medullary thyroid cancer. | ||
| Medical condition: The disease we will be studying is medullary thyroid carcinoma. This type of thyroid carcinoma constitutes approximately 10% of all thyroid cancers. Treatment consists of a total thyroidectomy and ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2022-001867-29 | Sponsor Protocol Number: 1081HV | Start Date*: 2022-11-02 |
| Sponsor Name:Amsterdam UMC | ||
| Full Title: [68Ga]Ga-FAPI-46 positron emission tomography in pancreaticobiliary cancers: a pharmacokinetics, repeatability and diagnostic accuracy study. | ||
| Medical condition: Pancreatic carcinoma and cholangiocarcinoma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-003713-33 | Sponsor Protocol Number: 70903 | Start Date*: 2020-03-02 | |||||||||||
| Sponsor Name:Princess Máxima Center for pediatric oncology | |||||||||||||
| Full Title: Diagnostic accuracy of neuroblastoma patient imaging with [18F]-mFBG PET-CT compared to [123]I-mIBG scanning | |||||||||||||
| Medical condition: Neuroblastoma | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-003167-38 | Sponsor Protocol Number: NL50643.09r.r4 | Start Date*: 2015-04-28 |
| Sponsor Name:Radboudumc | ||
| Full Title: 68Ga-NODAGA-exendin-4 PET/CT in patients with AHH - a prospective comparative evaluation of preoperative imaging Under the FP7 project Betacure (602812); Personalized diagnosis and treatment of hy... | ||
| Medical condition: Adult endogenous hyperinsulinemic hypoglycemia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) FI (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-002483-31 | Sponsor Protocol Number: UZBRU_VHH2_2 | Start Date*: 2020-11-30 |
| Sponsor Name:UZ Brussel | ||
| Full Title: Phase II study to evaluate the clinical potential of 68GaNOTA-Anti-MMR-VHH2 for in vivo imaging of MMR-expressing Macrophages by means of Positron Emission Tomography (PET) in oncological lesions, ... | ||
| Medical condition: C1: malignancies of the head and neck. C2: malignancy with a solid component C3: carotid plaque, planned for (SOC) carotid endarterectomy. C4: biopsy-proven Hodgkin or non-Hodgkin lymphoma. C5: su... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: BE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-003760-47 | Sponsor Protocol Number: 2018-14 | Start Date*: 2020-04-06 |
| Sponsor Name:Assistance Publique Hôpitaux de Marseille | ||
| Full Title: Evaluation of 68Ga-PSMA PET-CT in the initial extension assessment of advanced renal cell carcinoma a prospective, multicenter, open study | ||
| Medical condition: renal cell cancer (RCC) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-003805-71 | Sponsor Protocol Number: ICO-2020-25 | Start Date*: 2021-03-29 | |||||||||||
| Sponsor Name:INSTITUT DE CANCEROLOGIE DE L'OUEST | |||||||||||||
| Full Title: Prospective phase II pilot study, assessing imaging performance of 89Zirconium-labelled Girentuximab (89Zr-TLX250) PET-CT in metastatic triple negative breast cancer patients OPALESCENCE: zircOn P... | |||||||||||||
| Medical condition: Patients with Triple Negative Breast Cancer recurrence | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: FR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2015-001289-24 | Sponsor Protocol Number: AGO/2015/005 | Start Date*: 2015-07-13 |
| Sponsor Name:Ghent University Hospital | ||
| Full Title: 99m Tc- sestaMIBI/pertechnetaat SPECT subtractie beeldvorming versus 18F-Fluorocholine PET/CT voor de preoperatieve lokalisatie van hyperfunctionerende parathyroïden bij primaire hyperparathyroidie. | ||
| Medical condition: hyperfunctionerende parathyroïden | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-000370-30 | Sponsor Protocol Number: 20150706 | Start Date*: 2015-11-26 |
| Sponsor Name:Norrlands University Hospital | ||
| Full Title: Diagnosis and follow up of neuroendocrine tumours with 68Ga-DotaToc PET/CT | ||
| Medical condition: Neuroendocrine tumors | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-000121-37 | Sponsor Protocol Number: 2020-PSMA | Start Date*: 2020-06-09 | |||||||||||
| Sponsor Name:CYCLOPHARMA | |||||||||||||
| Full Title: A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer | |||||||||||||
| Medical condition: Patients with histopathologically confirmed prostate adenocarcinoma per original diagnosis and subsequent definitive therapy, with first biochemical recurrence | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: FR (Completed) BE (Completed) NL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2009-017587-16 | Sponsor Protocol Number: 006117 | Start Date*: 2010-12-02 |
| Sponsor Name:Barts Health NHS Trust | ||
| Full Title: Treatment monitoring using FDG-PET/CT and FLT-PET/CT in patients with Hodgkin Lymphoma. | ||
| Medical condition: Hodgkin Lymphoma | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-005157-24 | Sponsor Protocol Number: 75688 | Start Date*: 2021-09-21 | |||||||||||
| Sponsor Name:UMC Utrecht | |||||||||||||
| Full Title: [18F]mFBG PET-CT imaging of pheochromocytoma | |||||||||||||
| Medical condition: Pheochromocytoma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
